News >

Curating Novel Combinations in CLL

Caroline Seymour
Published: Tuesday, Sep 10, 2019

Tanya Siddiqi, MD, an associate professor and director of the Chronic Lymphocytic Leukemia Program at City of Hope

Tanya Siddiqi, MD

In what was once considered an incurable disease, multiple targeted therapies have emerged for patients with chronic lymphocytic leukemia (CLL), with the goal of providing deep remissions and improvements in overall survival (OS), explained Tanya Siddiqi, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication